Glioblastoma signature in the DNA of blood-derived cells.
Current approach for the detection of cancer is based on identifying genetic mutations typical to tumor cells. This approach is effective only when cancer has already emerged, however, it might be in a stage too advanced for effective treatment. Cancer is caused by the continuous accumulation of mut...
Guardado en:
Autores principales: | Siddharth Jain, Bijan Mazaheri, Netanel Raviv, Jehoshua Bruck |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb46b06b05994c9e84f745127c91a4bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intestinal mucosa-derived DNA methylation signatures in the penetrating intestinal mucosal lesions of Crohn’s disease
por: Yuan Li, et al.
Publicado: (2021) -
Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma.
por: Venkata Ramesh Dasari, et al.
Publicado: (2012) -
Peripheral blood cell signatures of Plasmodium falciparum infection during pregnancy.
por: Samad Ibitokou, et al.
Publicado: (2012) -
Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
por: Ya-Dan Wen, et al.
Publicado: (2021) -
The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.
por: Paola Ruggieri, et al.
Publicado: (2012)